'Distinguished Scholar Series' Brings National Experts to Roanoke
Monday, August 19, 2013
What makes a human brain human? What role does aging play in cancer
development? How can robotics help restore quality of life to stroke
survivors? What are the latest advances in the genetics of autism? And
what role does the public play in biomedical research? The fourth
annual season of public lectures in the Virginia Tech Carilion Research
Institute’s Distinguished Scholars Series will bring leading experts in
biomedical and health research from across the nation to Roanoke to
answer these and other questions.
Dr. Ronald DePinho, one of the
world’s leading oncologists and cancer researchers, will talk about how
cancers affect us as we age. Terrence Sejnowski, the Francis Crick Chair
at the Salk Institute for Biological Studies in La Jolla, Calif., will
discuss what makes a human brain human. Dr. Gary Gibbons, director of
the National Heart, Lung, and Blood Institute of the National Institutes
of Health, will discuss his vision for a diverse, adaptive, and
networked biomedical science enterprise.
Other topics in the
upcoming series will include the family-wide impacts of such genetic
diseases as fragile X syndrome, the use of robotic assistance in
rehabilitation for stroke survivors, the translation of genetic
mutations into therapeutic targets for cardiac rehabilitation, the Obama
administration’s BRAIN Initiative, the use of deep brain stimulation in
treating resistant depression, and the mechanisms by which viruses
infect the nervous system.
The lectures, which are free and open
to the public, will take place on Thursdays from 5:30 to 6:30 p.m. at
the Virginia Tech Carilion Research Institute at 2 Riverside Circle in
Roanoke. A free public reception will precede each lecture at 5:00 p.m.
For a complete schedule, visit the institute’s website.